Article citationsMore>>

Zhou, Z., Sehn, L.H., Rademaker, A.W., et al. (2014) An Enhanced International Prognostic Index (NCCN-IPI) for Patients with Diffuse Large B-Cell Lymphoma Treated in the Rituximab Era. Blood, 123, 837-842.
https://doi.org/10.1182/blood-2013-09-524108

has been cited by the following article:

SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top